Recruiting

Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study

Sponsor:

Sanofi

Code:

NCT05991323

Conditions

Prurigo Nodularis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dupilumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by Sanofi on 2025-03-25.